Met Life Investment Management, LLC Co Diagnostics, Inc. Transaction History

Met Life Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $21,164 - $28,259	-2,956 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$8.52 - $19.21 $25,185 - $56,784	2,956 New	2,956 $28,000
Q1 2021 Jun 26, 2023	BUY	$8.52 - $19.21 $25,185 - $56,784	2,956 New	2,956 $28.2 Million
Q1 2021 Mar 22, 2023	SELL	$8.52 - $19.21 $79,542 - $179,344	-9,336 Reduced 75.95%	2,956 $28,000
Q1 2021 May 14, 2021	SELL	$8.52 - $19.21 $79,542 - $179,344	-9,336 Reduced 75.95%	2,956 $28,000
Q4 2020 Jun 22, 2023	BUY	$9.3 - $15.19 $114,315 - $186,715	12,292 New	12,292 $114,000
Q3 2020 Jun 26, 2023	BUY	$8.24 - $30.8 $101,286 - $378,593	12,292 New	12,292 $167,000
Q2 2020 May 24, 2024	BUY	$7.46 - $23.42 $91,698 - $287,878	12,292 New	12,292 $238 Million
Q2 2020 Jun 26, 2023	BUY	$7.46 - $23.42 $91,698 - $287,878	12,292 New	12,292 $237,000
Q2 2020 Mar 22, 2023	BUY	$7.46 - $23.42 $91,698 - $287,878	12,292 New	12,292 $237,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $91,698 - $287,878	12,292 New	12,292 $238,000

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.